Xenon Pharmaceuticals Inc. Annual Earnings Per Share, Basic in USD/shares from 2012 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Xenon Pharmaceuticals Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2012 to 2023.
  • Xenon Pharmaceuticals Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.81 USD/shares, a 11% decline year-over-year.
  • Xenon Pharmaceuticals Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -2.83 USD/shares, a 5.99% decline year-over-year.
  • Xenon Pharmaceuticals Inc. annual Earnings Per Share, Basic for 2023 was -2.73 USD/shares, a 32.5% decline from 2022.
  • Xenon Pharmaceuticals Inc. annual Earnings Per Share, Basic for 2022 was -2.06 USD/shares, a 16.4% decline from 2021.
  • Xenon Pharmaceuticals Inc. annual Earnings Per Share, Basic for 2021 was -1.77 USD/shares, a 119% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$3 -$1 -32.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 -$2 $0 -16.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 -$2 -$1 -119% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 -$1 Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2018 -$2 +$0.08 +4.68% Jan 1, 2018 Dec 31, 2018 10-K 2019-03-06
2017 -$2 $0 -15.5% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-06
2016 -$1 $0 -34.5% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-07
2015 -$1 -$5 -127% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-07
2014 $4.11 +$1.24 +43.2% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-08
2013 $2.87 +$6.11 Jan 1, 2013 Dec 31, 2013 10-K 2016-03-08
2012 -$3 Jan 1, 2012 Dec 31, 2012 10-K 2015-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.